Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distributionAgnès Girard, James A. Retsema, D Girard et al.|Antimicrobial Agents and Chemotherapy|1987Cited by 323
Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.G. Michael Bright, Rachel J. Mason, James A. Retsema et al.|The Journal of Antibiotics|1988Cited by 238
Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivoJames A. Retsema, William B. Milisen, Agnès Girard et al.|Journal of Antimicrobial Chemotherapy|1990Cited by 74
Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infectionAgnès Girard, James A. Retsema, D Girard|Journal of Antimicrobial Chemotherapy|1990Cited by 73
Preferential concentration of azithromycin in an infected mouse thigh modelJames A. Retsema, Agnès Girard, Jay Bergeron et al.|Journal of Antimicrobial Chemotherapy|1993Cited by 63